According to Zhitong Finance App News, Olin Biotech (688319.SH) disclosed its 2023 annual report. The company achieved revenue of 496 million yuan in 2023, a year-on-year decrease of 9.38%; net profit to mother was 17.56 million yuan, a year-on-year decrease of 33.94%; after deducting non-net profit of 3.39 million yuan, an increase of 370.1% year on year; basic earnings per share were 0.0433 yuan. The company plans to pay a cash dividend of 0.38 yuan (tax included) for every 10 shares.